Muscle cell-derived factors inhibit inflammatory stimuli-induced damage inhMSC-derived chondrocytes

Osteoarthritis and Cartilage

Volumn 21, Issue 7, 2013, Pages 990-998

  Rainbow, R S ^a   Kwon, H ^a,b   Foote, A T ^a   Preda, R C ^c   Kaplan, D L ^c   Zeng, L ^a,b,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c Tufts University   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Cartilage tissue engineering; Cytokines; Myokines; Osteoarthritis; Pro inflammatory; Stem cells

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; INTERLEUKIN 1BETA; KI 67 ANTIGEN; MATRIX PROTEIN; PROTEIN P53; SILK; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL AGING; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HISTOLOGY; MESENCHYMAL STEM CELL; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING;

AGGRECANS; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 3; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHONDROCYTES; COLLAGEN TYPE II; COLLAGEN TYPE X; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FIBROBLASTS; GENE PRODUCTS, GAG; HUMANS; INTERLEUKIN-1BETA; KI-67 ANTIGEN; MATRIX METALLOPROTEINASES; MESENCHYMAL STROMAL CELLS; MYOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879464706     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.04.011     Document Type: Article

References (45)

1. Little C.J., Bawolin N.K., Chen X. Mechanical properties of natural cartilage and tissue-engineered constructs. Tissue Eng Part B Rev 2011 Aug, 17(4):213-227.
2. Huang A.H., Yeger-McKeever M., Stein A., Mauck R.L. Tensile properties of engineered cartilage formed from chondrocyte- and MSC-laden hydrogels. Osteoarthritis Cartilage 2008 Sep, 16(9):1074-1082.
3. Hootman J.M., Helmick C.G. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006 Jan, 54(1):226-229.
4. Mahmoudifar N., Doran P.M. Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends Biotechnol 2012 Mar, 30(3):166-176.
5. Wieland H.A., Michaelis M., Kirschbaum B.J., Rudolphi K.A. Osteoarthritis - an untreatable disease?. Nat Rev Drug Discov 2005 Apr, 4(4):331-344.
6. Gadjanski I., Spiller K., Vunjak-Novakovic G. Time-Dependent processes in stem cell-based tissue engineering of articular cartilage. Stem Cell Rev 2011 Oct 21.
7. Wescoe K.E., Schugar R.C., Chu C.R., Deasy B.M. The role of the biochemical and biophysical environment in chondrogenic stem cell differentiation assays and cartilage tissue engineering. Cell Biochem Biophys 2008, 52(2):85-102.
8. Rockwood D.N., Preda R.C., Yucel T., Wang X., Lovett M.L., Kaplan D.L. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 2011 Oct, 6(10):1612-1631.
9. Meinel L., Hofmann S., Karageorgiou V., Zichner L., Langer R., Kaplan D., et al. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng 2004 Nov 5, 88(3):379-391.
10. Hofmann S., Knecht S., Langer R., Kaplan D.L., Vunjak-Novakovic G., Merkle H.P., et al. Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng 2006 Oct, 12(10):2729-2738.
11. Wang Y., Kim U.J., Blasioli D.J., Kim H.J., Kaplan D.L. Invitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 2005 Dec, 26(34):7082-7094.
12. Lima E.G., Tan A.R., Tai T., Bian L., Stoker A.M., Ateshian G.A., et al. Differences in interleukin-1 response between engineered and native cartilage. Tissue Eng Part A 2008 Oct, 14(10):1721-1730.
13. Francioli S., Cavallo C., Grigolo B., Martin I., Barbero A. Engineered cartilage maturation regulates cytokine production and interleukin-1beta response. Clin Orthop Relat Res 2011 Oct, 469(10):2773-2784.
14. Goldring M.B., Otero M., Tsuchimochi K., Ijiri K., Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008 Dec, 67(Suppl 3):iii75-82.
15. Pelletier J.P., Martel-Pelletier J., Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001 Jun, 44(6):1237-1247. [Review].
16. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011 Sep, 23(5):471-478.
17. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011 Jan, 7(1):33-42.
18. Sun L., Wang X., Kaplan D.L. A3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis. Biomaterials 2011 Aug, 32(24):5581-5589.
19. Buckingham M., Bajard L., Chang T., Daubas P., Hadchouel J., Meilhac S., et al. The formation of skeletal muscle: from somite to limb. JAnat 2003 Jan, 202(1):59-68.
20. Knobloch T.J., Madhavan S., Nam J., Agarwal S., Agarwal S. Regulation of chondrocytic gene expression by biomechanical signals. Crit Rev Eukaryot Gene Expr 2008, 18(2):139-150.
21. Scott D., Blizzard L., Fell J., Jones G. Prospective study of self-reported pain, radiographic osteoarthritis, sarcopenia progression, and falls risk in community-dwelling older adults. Arthritis Care Res (Hoboken) 2012 Jan, 64(1):30-37.
22. Slemenda C., Heilman D.K., Brandt K.D., Katz B.P., Mazzuca S.A., Braunstein E.M., et al. Reduced quadriceps strength relative to body weight: a risk factor for knee osteoarthritis in women?. Arthritis Rheum 1998 Nov, 41(11):1951-1959.
23. Roos E.M., Herzog W., Block J.A., Bennell K.L. Muscle weakness, afferent sensory dysfunction and exercise in knee osteoarthritis. Nat Rev Rheumatol 2011 Jan, 7(1):57-63.
24. Drachman D., Sokoloff L. The role of movement in embryonic joint development. Dev Biol 1966, 14:401.
25. Hao Y., Ma Y., Wang X., Jin F., Ge S. Short-term muscle atrophy caused by botulinum toxin-A local injection impairs fracture healing in the rat femur. JOrthop Res 2012 Apr, 30(4):574-580.
26. Rehan Youssef A., Longino D., Seerattan R., Leonard T., Herzog W. Muscle weakness causes joint degeneration in rabbits. Osteoarthritis Cartilage 2009 Sep, 17(9):1228-1235.
27. Evans C.H., Liu F.J., Glatt V., Hoyland J.A., Kirker-Head C., Walsh A., et al. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater 2009, 18:96-111.
28. Knapp J.R., Davie J.K., Myer A., Meadows E., Olson E.N., Klein W.H. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development 2006 Feb, 133(4):601-610.
29. Elkasrawy M., Immel D., Wen X., Liu X., Liang L.F., Hamrick M.W. Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing. JHistochem Cytochem 2012 Jan, 60(1):22-30.
30. Cairns D.M., Lee P.G., Uchimura T., Seufert C.R., Kwon H., Zeng L. The role of muscle cells in regulating cartilage matrix production. JOrthop Res 2010 Apr, 28(4):529-536.
31. Cairns D.M., Uchimura T., Kwon H., Lee P.G., Seufert C.R., Matzkin E., et al. Muscle cells enhance resistance to pro-inflammatory cytokine-induced cartilage destruction. Biochem Biophys Res Commun 2010 Jan 29, 392(1):22-28.
32. Goldberg R.L., Kolibas L.M. An improved method for determining proteoglycans synthesized by chondrocytes in culture. Connect Tissue Res 1990, 24(3-4):265-275.
33. Vincenti M.P., Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002, 4(3):157-164.
34. Wehling N., Palmer G.D., Pilapil C., Liu F., Wells J.W., Muller P.E., et al. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum 2009 Mar, 60(3):801-812.
35. van der Kraan P.M., van den Berg W.B. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?. Osteoarthritis Cartilage 2012 Mar, 20(3):223-232.
36. Steinert A.F., Ghivizzani S.C., Rethwilm A., Tuan R.S., Evans C.H., Noth U. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 2007, 9(3):213.
37. Johnston J.B. Asimple, nondestructive assay for bound hyaluronan. JBiomed Mater Res 2000, 53(2):188-191.
38. Zhang H. Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging. JCell Physiol 2007 Mar, 210(3):567-574.
39. Loeser R.F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 2009 Aug, 17(8):971-979.
40. Carames B., Lopez-Armada M.J., Cillero-Pastor B., Lires-Dean M., Vaamonde C., Galdo F., et al. Differential effects of tumor necrosis factor-alpha and interleukin-1beta on cell death in human articular chondrocytes. Osteoarthritis Cartilage 2008 Jun, 16(6):715-722.
41. Lopez-Armada M.J., Carames B., Lires-Dean M., Cillero-Pastor B., Ruiz-Romero C., Galdo F., et al. Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthritis Cartilage 2006 Jul, 14(7):660-669.
42. Pedersen B.K. Muscles and their myokines. JExp Biol 2011 Jan 15, 214(Pt 2):337-346.
43. Lefevre S., Knedla A., Tennie C., Kampmann A., Wunrau C., Dinser R., et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009 Dec, 15(12):1414-1420.
44. Kislinger T., Gramolini A.O., Pan Y., Rahman K., MacLennan D.H., Emili A. Proteome dynamics during C2C12 myoblast differentiation. Mol Cell Proteomics 2005 Jul, 4(7):887-901.
45. Goldring M.B., Otero M., Plumb D.A., Dragomir C., Favero M., El Hachem K., et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 2011, 21:202-220.